J
Jazz Pharmaceuticals plc
Q3 2026 earnings expected
Quarter
Jul – Sep
Expected
November 4, 2026(ET)
Revenue
This quarter$1.2B
Analyst estimate$1.2B▲ +0.0%
Year ago (Sep '25)$1.1B▲ +7.3%
Revenue Growth Trajectory
+16%YoY
Last 6 quarters
Analyst consensus · $1.2B · 11 analysts
As of 9/2, 12:00 KST